Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.70 | N/A | +0.08% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.70 | N/A | +0.08% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about the current retail landscape and indicated that adjustments may be necessary to navigate these challenges.
Management noted challenges in the retail environment.
They emphasized the need for strategic adjustments moving forward.
The earnings report shows that Prestige Consumer HE managed to beat EPS expectations slightly, but the stock fell significantly by over 10%. This decline may reflect investor concerns about the broader retail environment and the lack of revenue data. The absence of guidance could also contribute to uncertainty among investors.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
RAMBUS INC DEL
Jan 29, 2018